Our CEO, Aileen Lai, provides her views in latest edition of Pharma Focus Asia Magazine on Precision Medicine as The Future of Pharma.

As the advisory board member of Pharma Focus Asia Magazine, I was requested by the editorial team to provide my view on Precision Medicine as The Future of Pharma. Precision medicine has been in conversation the past 20 years, if not, longer. I felt the burning need in sharing the excerpt of my view. The healthcare industry had transformed with the adoption of technology today and will continue to leapfrog in the years to come. Technology will play a crucial role in the transformation of precision medicine or should we call it 'Precision Healthcare'.

"Precision medicine has benefitted patients worldwide tremendously with enhanced treatment efficacy, minimised side effects and improved patient outcomes. The next cutting edge innovation will be technology aided precision medicine providing specific, accurate and up-to-date patient data to support treatment course, patient education and adherence and follow-up for ongoing adjustments and improvements.

The large amount of data collected through the innovative, consistent and invested adoption of technology in precision medicine will support the acceleration of the entire drug development process, supporting revolutionary leapfrogging in new, improved and most importantly, reduction in overall cost of precision medicine."

To read about Aileen Lai's LinkedIn post, please click here.